| 영문 | immunoglobulin | 한글 | 면역글로불린 |
|---|---|---|---|
| 설명 | 혈청성분 중 면역에 중요한 역할을 하고, 또 항체 작용을 하는 단백질의 총칭. 항체 작용이란 항원에 선택적으로 반응하는 기능인데, 이 작용을 하는 것은 대부분 전기이동법으로 나눌 경우 감마 영역에 속하므로 감마글로불린이라고도 한다. 기본구조는 분자량 약 2만 3,000의 L사슬(가벼운 사슬) 한 쌍과 5만~7만의 H사슬(무거운 사슬) 한 쌍이 S-S 다리걸침에 의해 결합된 것이다.  |
||
| 영문 | acquired immunodeficiency syndrome | 한글 | 후천면역결핍증후군, 에이즈 |
|---|---|---|---|
| 설명 | 인간면역결핍바이러스(HIV)에 의하여 면역 세포가 파괴됨으로써 인체의 면역능력이 극도로 저하되어 병원체에 대하여 무방비 상태에 이르는 병. 에이즈 바이러스의 감염으로 생기며, 1981년 미국에서 처음 보고되었다. 최초 감염으로부터 증상이 나타나기까지는 평균 10년 정도 걸리며 사망률이 대단히 높다. 성적 접촉, 오염 주사기 사용, 오염 혈액 및 혈액 제제 사용, 에이즈 산모로부터 수직감염 따위에 의하여 감염된다. 감염 후 일과성으로 감기와 같은 증상을 보이며 바이러스혈증으로 되지만 바이러스는 감소되고 6~8주 후에는 항체가 양성으로 된다. 6~10년 정도의 무증후성 보균기간을 지나서 에이즈관련증후군(AIDS related syndrome)으로 된다. 저항력의 감소, 림프절비대, 체중감소, 발열, 만성설사가 이어진다. 그 후 에이즈로 되며, 폐포자충폐렴 등의 원충병, 칸디다 등의 진균증, 헤르페스바이러스군 등의 기회감염이 이어진다. 또한 카포시육종, 림프종 등을 병발해서 사망한다. 바이러스의 뇌조직내 증식으로 치매를 일으킬 수도 있다. HIV-1은 10년간에 사망률이 90%, HIV-2는 10%이다. |
||
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| CID | cellular immunodeficiency; charge injection device; chick infective dose; combined immunodeficiency ... |
| MIg | malaria immunoglobulin; measles immunoglobulin; membrane immunoglobulin |
| NAD | neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini... |
| HIV/AIDS | Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome |
|---|---|
| AIMS | Abnormal Involuntary Movement Scale |
| AIM | abnormal involuntary movement |
| AUB | Abnormal Uterine Bleeding |
| Awd | Abnormal wing disc |
| cellular immunodeficiency with abnormal immunoglobulin synthesis | An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal. Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia. (05 Mar 2000) |
|---|
| abnormal | Not normal, contrary to the usual structure, position, behaviour or rule. (06 Oct 1997) |
|---|---|
| abnormal cleavage of cardiac valve | Congenital malformation of a valve leaflet with a defect extending from the free margin. (05 Mar 2000) |
| abnormal correspondence | Abnormal correspondence, a condition, frequent in strabismus, in which corresponding retinal points do not have the same visual direction; the fovea of one eye corresponds to an extrafoveal area of the fellow eye. Synonym: abnormal correspondence. (05 Mar 2000) |
| abnormal heart chamber dimensions | <radiology> Left ventricular volume overload, left ventricular hypertrophy, right ventricular volume overload, right ventricular hypertrophy, fixed subvalvular aortic stenosis, hypoplastic left/right ventricle; common ventricle, congestive cardiomyopathy (12 Dec 1998) |
| abnormal occlusion | An arrangement of the teeth which is not considered to be within the normal range of variation. (05 Mar 2000) |
| abnormal placental size | <radiology> TOO BIG (greater than5cm in sections obtained at right angles to the long axis), maternal disease, diabetic mothers (= villous oedema), intrauterine infections, anaemic mothers (= normal histology), foetal disease, erythroblatosis foetalis (= villous oedema and hyperplasia), umbilical vein obstruction, foetal high output failure, large chorioangioma, sacrococcygeal teratoma, arteriovenous fistula too small, preeclampsia (associated with placental infarcts in 33-60%) (12 Dec 1998) |
| reflex, abnormal | Abnormal, involuntary response to a stimulus which includes hyperreflexia, hyporeflexia, and areflexia. (12 Dec 1998) |
| haemoglobins, abnormal | Haemoglobins altered in their genetically determined molecular structure, resulting in a characteristic complex of vlinival and laboratory abnormalities. The specific features of the abnormal haemoglobins are related to variation of the composite globin polypeptide chains. (12 Dec 1998) |
| pupillary functions, abnormal | Conditions in which the pupil does not react normally to dilation and constriction. Signs of pupillary abnormalities originate from the pupil's shape, position, and response to stimulation. (12 Dec 1998) |
| fibrinogens, abnormal | Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilised fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenaemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing. (12 Dec 1998) |
| vectorial synthesis | <cell biology> Term usually applied to the mode of synthesis of proteins destined for export from the cell. As the protein is made it moves (vectorially) through the membrane of the rough endoplasmic reticulum, to which the ribosome is attached and into the cisternal space. (06 Mar 2000) |
| gene synthesis | <molecular biology> The complete synthesis of a gene using a DNA synthesiser (gene machine), or the assembly of oligonucleotides so synthesised into a synthetic gene, as opposed to cloning. (14 Nov 1997) |
| cell-free protein synthesis | <technique> An in vitro method to make proteins, using amino acids, the mRNA corresponding to the protein to be made, and a cell-free extract (the contents of a cell after removal of the cell wall and/or outer cell membranes) for other needed components and enzymes. (26 Mar 1998) |
| Merrifield synthesis | The synthesis of peptides and proteins via an automated system on carrier polymers. (05 Mar 2000) |
| chiral synthesis | <chemistry> The production of chiral compounds in only one enantiomer, or handedness. (See chirality) (05 Jan 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|